Cargando…
The Uremic Toxin Indoxyl Sulfate Accelerates Thrombotic Response after Vascular Injury in Animal Models
Chronic kidney disease (CKD) patients are at high risk for thrombotic events. Indoxyl sulfate (IS) is one of the most potent uremic toxins that accumulates during CKD. Even though IS is associated with an increased risk for cardiovascular disease, its impact on thrombotic events still remains not fu...
Autores principales: | Karbowska, Malgorzata, Kaminski, Tomasz W., Marcinczyk, Natalia, Misztal, Tomasz, Rusak, Tomasz, Smyk, Lukasz, Pawlak, Dariusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535176/ https://www.ncbi.nlm.nih.gov/pubmed/28753957 http://dx.doi.org/10.3390/toxins9070229 |
Ejemplares similares
-
Neurobehavioral effects of uremic toxin–indoxyl sulfate in the rat model
por: Karbowska, Malgorzata, et al.
Publicado: (2020) -
Indoxyl sulfate – the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease
por: Kamiński, Tomasz W., et al.
Publicado: (2017) -
The impact of antihypertensive pharmacotherapy on interplay between protein-bound uremic toxin (indoxyl sulfate) and markers of inflammation in patients with chronic kidney disease
por: Kaminski, Tomasz W., et al.
Publicado: (2019) -
Indoxyl Sulfate Promotes Arterial Thrombosis in Rat Model via Increased Levels of Complex TF/VII, PAI-1, Platelet Activation as Well as Decreased Contents of SIRT1 and SIRT3
por: Karbowska, Malgorzata, et al.
Publicado: (2018) -
Association between uremic toxin-anthranilic acid and fibrinolytic system activity in predialysis patients at different stages of chronic kidney disease
por: Kaminski, Tomasz W., et al.
Publicado: (2017)